Swiss ingredients brand HeiQ has acquired Chrisal N.V., a Belgian industrial biotechnology company, expanding its offering to include probiotic ingredients and technology platforms. HeiQ reported it had acquired 51 percent of the share capital and voting rights of Chrisal, which will be renamed HeiQ Chrisal. The purchase price amounts to €7.5 million, including €5.0 million in cash and €2.5 million through the issuance of 1.101 million new ordinary shares by HeiQ, the company previously indicated. Chrisal develops innovative ingredients and consumer products that incorporate the benefits of probiotics and synbiotics. It has three technology platforms, all with the purpose of creating healthy and sustainable microbial ecosystems. Applications of the company’s proprietary technology include cosmetics, personal care, textiles, wound dressings, water treatment, air treatment and cleaning products. Chrisal has its office, production site and bottling facilities in Lommel, Belgium.